Cited by 117Acne and Rosacea Treatments and EffectsPeroxisome Proliferator-Activated ReceptorsDermatology and Skin Diseases

Testosterone metabolism to 5?-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes

Makrantonaki, E., Zouboulis, C.C.·2007·British Journal of Dermatology

Abstract

BACKGROUND: Despite the clinical evidence that androgens stimulate sebaceous lipids, androgens in vitro have shown no similar effects. This contradiction led to the assumption that cofactors may be required for lipid regulation and peroxisome proliferator-activated receptor (PPAR) ligands were suggested to be adequate candidates. OBJECTIVES: The influence of testosterone and linoleic acid, a PPAR ligand, as single agents and in combination with of LY191704, a 5alpha-reductase type I inhibitor, was examined on 5alpha-dihydrotestosterone (5alpha-DHT) synthesis and lipid content in human SZ95 sebocytes. METHODS: Cell proliferation and viability were measured by the 4-methylumbelliferyl heptanoate fluorescence assay and by the Boehringer Lactate Dehydrogenase Assay kit, respectively. 5alpha-DHT enzyme-linked immunosorbent assay was used for the detection of 5alpha-DHT synthesis in cell supernatants after treatment, whereas lipid production was documented by means of the Nile red lipid microassay and fluorescence microscopy. RESULTS: Testosterone promoted 5alpha-DHT synthesis (P < 0.001), whereas linoleic acid increased sebaceous lipids (P < 0.001). The combination of testosterone and linoleic acid exhibited a synergistic effect on the synthesis of 5alpha-DHT (P < 0.01 vs. testosterone) and sebaceous lipids (P < 0.01 vs. linoleic acid). Furthermore, LY191704 reduced 5alpha-DHT and sebaceous lipid levels (P < 0.01 and P < 0.001 in comparison with testosterone/linoleic acid, respectively). Cell proliferation and viability remained unchanged under treatment with all compounds tested. CONCLUSIONS: These data suggest a catalytic effect of PPAR ligands on cellular testosterone activation by 5alpha-reduction and the importance of the latter for the regulation of sebaceous lipids.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.2006.07671.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Makrantonaki, E., & Zouboulis, C. C.
Affiliations
  • Stiftung Charité (DE)
  • Städtisches Klinikum Dessau (DE)
Corresponding author
Zouboulis, C.C.
Venue
British Journal of Dermatology
Published
2007-03
Volume
156
Issue
3
Pages
428-432
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2032483892
Cited by
117
References
22
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 7 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 14 · 2013: 3 · 2012: 6
FWCI
9.13
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
testosterone metabolism, dihydrotestosterone, sebaceous lipids, linoleic acid, peroxisome proliferator-activated receptors, sebocytes, synergistic effect, cell proliferation
MeSH terms
Androstanols, Cells, Cultured, Drug Synergism, Humans, Ligands, Lipids, Sebaceous Glands, Testosterone, 17-Ketosteroids, Quinolones, Linoleic Acid, Peroxisome Proliferator-Activated Receptors, Cell Proliferation, 5-alpha Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review